The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy

Angelina Tjokrowidjaja*, David Goldstein, H. Malcolm Hudson, Sarah J. Lord, Val Gebski, Stephen Clarke, Paul de Souza, Robert J. Motzer, Chee Khoon Lee

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    3 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy'. Together they form a unique fingerprint.

    Medicine & Life Sciences